Following The Culture Trail
Amitabh Dube, country president of Novartis India, has travelled extensively, but it is his stay in Vietnam that he most fondly remembers, not just for its food, people and landscape but also for the footprints of Indian culture in the southeast Asian country
Chitra Nair - July 29, 2023
Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?
Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh
V Keshavdev - December 10, 2020
A Growing Appetite
Banking on acquisitions, Torrent Pharma is focused on strengthening its presence in the domestic market
Krishna Gopalan - November 28, 2017
At Home With Art
Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art
Krishna Gopalan - August 19, 2017
Under The Weather - Part 2
Even as it battles the US FDA, the industry has been caught off-guard by policy changes back home
Krishna Gopalan - June 05, 2017
Under The Weather- Part 1
The domestic pharma industry, which is already battling the US FDA, has now to contend with regulatory challenges at home
Krishna Gopalan - May 20, 2017
Managing Growth 2017- Part 2
Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal
March 17, 2017
Making A Fresh Start
CEOs from diverse sectors on what's in store for 2017
March 17, 2017
Growth eclipse
After a dream run, Sun Pharma is grappling with growth and regulatory issues. Can the country’s biggest drug maker rediscover its mojo?
Krishna Gopalan - January 22, 2016
Cash-rich picks in the current market
Looking for cash bargains? Here is a first cut list
Jitendra Kumar Gupta - August 26, 2015
